The global healthcare sector is under sustained pressure to deliver more with less.
Pricing and Reimbursement strategy is key to product uptake and WG's customer-centric approach helps marketers define and demonstrate brand value.
Demand for healthcare is growing. The cost of disease is escalating. The need to reduce variations in care and improve health outcomes remains a priority.
New leading-edge medical innovations are being developed, but as healthcare spending is constrained, many patients are being denied access to them.
The pricing and reimbursement of medicines is a global challenge. Defining, demonstrating and delivering value is key.
In the ongoing journey towards market access, the development of a responsive and fully-integrated value proposition is essential. Understanding the needs
of every stakeholder across a multi-disciplinary customer-base is vital. Only joined-up thinking will do. And WG is the expert.
WG adopts a comprehensive cross-functional approach to the development of health economic and outcomes research (HEOR) strategies.
Its in-house team of experienced health economists work in tandem with clinical, payer and marketing experts to ensure HEOR strategies are joined up.
The team partners with key external healthcare stakeholders to develop holistic insight-driven strategies for clients.
This integrated approach delivers evidence-based results that increase the likelihood of market access and ultimately lead to better outcomes for patients.
Unlike standalone health economics agencies, WG does not develop strategy in a health economics silo. It uses joined-up thinking. It’s the only way to deliver better outcomes.
Health Economics and Outcomes Research cannot operate in a silo. Developing the optimal brand value proposition depends on taking a
cross-functional approach; HEOR strategies led by experienced health economists and optimised by integrating clinical, payer and marketing insights expertise.
WG is not an agency - it's a full-service consultancy. It has holistic experience - and it's all joined up.
The in-house review team combines clinical and health economic expertise, enabling it to understand interventions
in their clinical context as well as their likely impact on the health economy.
TOOLS AND SOLUTIONS
WG develops cost-effectiveness models, budget impact models, cost-benefit and cost-minimisation tools.
It has established global models that can be adapted locally.
WG boasts unparalleled access to healthcare academics and health economic experts which, in combination with its high level of
in-house expertise, enables it to provide robust and rounded health economic advice.
WG understands the success of a core value dossier is through evidence based research and is able to provide expert services in:
- Systematic reviews
- Mixed treatment and indirect comparison